Zeldox Bold Interaction Warning, Not Black Box, Needed For QTc - Committee

Labeling for Pfizer's Zeldox (ziprasidone) should clearly warn against combination use with other drugs that may prolong the QTc interval, but a black box may not be necessary, FDA's Psychopharmacological Drugs Advisory Committee suggested July 19.

More from Archive

More from Pink Sheet